Use of transvaginal and transabdominal cerclage in the Nordic countries: A survey of incidences and indications
Acta Obstetricia et Gynecologica Scandinavica · 2026-11-15
DOI: 10.1111/aogs.70391 ↗At a glance
Journal article in Acta Obstetricia et Gynecologica Scandinavica, published online on 2026-11-15. Written by Catharina Hein Hoffmann and 10 co-authors. Institution: Department of Gynecology and Obstetrics, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark. 27 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Novo Nordisk Fonden.
Abstract (original language)
Introduction
Clinical guidelines for cervical cerclage vary in terms of indications and patient management. In this study, we investigated the incidence, indications, surgical techniques, timing of placement, and peri‐ and postoperative care for both transvaginal and transabdominal cerclage use in the Nordic countries. Material and Methods This study was a cross‐sectional survey. An electronic questionnaire was developed and distributed via an electronic data capture system (REDCap) to an obstetrician from all birth units in Denmark, Finland, Iceland, Norway, and Sweden. The primary outcome was the reported incidence of transvaginal cerclage, both history‐ and ultrasound‐indicated, and of transabdominal cerclage.
Results
The estimated incidence per 100 000 births of history‐indicated transvaginal cerclage was 231 in DK, 70 in FI, 140 in IS, 133 in NO, and 166 in SE. For ultrasound‐indicated transvaginal cerclage, the estimated incidence per 100 000 births was 166 in DK, 21 in FI, 140 in IS, 17 in NO, and 59 in SE. For transabdominal cerclage, the estimated incidence was 63 in DK, 7 in FI, 28 in IS, 31 in NO, and 18 in SE.
Conclusions
There is substantial variation in the use of cervical cerclage between the Nordic countries. We advocate for a harmonized Nordic model of cerclage care to ensure equitable and consistent practice across countries, coupled with a Nordic research collaboration network that can drive knowledge generation and implementation across the region.
Subjects
Author keywords
Authors and institutions
- Department of Gynecology and Obstetrics, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Department of Obstetrics and Gynecology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Obstetrics and Gynecology, Skåne University Hospital, Lund, Sweden.
- Department of Clinical Sciences, Obstetrics and Gynaecology, Faculty of Medicine, Lund University, Lund, Sweden.
- Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
ORCID profiles: Catharina Hein Hoffmann, Lea Kirstine Hansen, Oskari Heikinheimo, Hulda Hjartardóttir, Bo Jacobsson, Niels Uldbjerg, Lone Krebs, Julie Glavind
Funding
- Novo Nordisk Fonden
Cite
APA
Hoffmann, C. H., Hansen, L. K., Lantto, A., Heikinheimo, O., Hald, K., Hjartardóttir, H., Jacobsson, B., Karypidis, H., Uldbjerg, N., Krebs, L., & Glavind, J. (2026). Use of transvaginal and transabdominal cerclage in the Nordic countries: A survey of incidences and indications. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.70391
Vancouver
Hoffmann CH, Hansen LK, Lantto A, Heikinheimo O, Hald K, Hjartardóttir H, et al. Use of transvaginal and transabdominal cerclage in the Nordic countries: A survey of incidences and indications. Acta Obstetricia et Gynecologica Scandinavica. 2026. doi:10.1111/aogs.70391
BibTeX
@article{Hoffmann2026,
author = {Hoffmann, Catharina Hein and Hansen, Lea Kirstine and Lantto, Annie and Heikinheimo, Oskari and Hald, Kirsten and Hjartardóttir, Hulda and Jacobsson, Bo and Karypidis, Helena and Uldbjerg, Niels and Krebs, Lone and Glavind, Julie},
title = {Use of transvaginal and transabdominal cerclage in the Nordic countries: A survey of incidences and indications},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2026},
doi = {10.1111/aogs.70391}
}
EUVIMED